REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS (Tables)

3 Months Ended

Mar. 31, 2022

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS

Schedule of revision to financial statements

	At December 31, 2021
Consolidated Balance Sheet ($ in millions)	As Previously Reported		Adjustments		As Revised
Accrued contract costs	$	585	$	(87)	$	498
Total current liabilities		4,544		(87)		4,457
Other liabilities		501		22		522
Total liabilities		10,511		(65)		10,446
Common stock, par value $0.01 per share, and additional paid-in capital (1,000.0 shares authorized, 224.2 shares issued)		4,218		66		4,284
Accumulated other comprehensive income/(loss)		(1,143)		(1)		(1,143)
Total stockholders’ equity before non-controlling interests		2,700		65		2,765
Total equity		2,702		65		2,767

	At March 31, 2021
Consolidated Statement of Equity ($ in millions)	As Previously Reported		Adjustments		As Revised
Net parent investment	$	5,976	$	51	$	6,027
Accumulated other comprehensive income (loss)		(1,186)		4		(1,182)
Total equity		4,848		54		4,902

	At January 1, 2021
Consolidated Statement of Equity ($ in millions)	As Previously Reported		Adjustments		As Revised
Net parent investment	$	5,972	$	51	$	6,023
Accumulated other comprehensive income (loss)		(1,100)		4		(1,096)
Total equity		4,931		54		4,985